Related Experiment Video
Updated: Mar 6, 2026

10:33
Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
22.0K
Glucose-Triggered Insulin Release from Fe3+ -Cross-linked Alginate Hydrogel: Experimental Study and Theoretical
Sabrina Scheja1,2, Sergii Domanskyi3, Maria Gamella1
1Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, NY, 13699-5810, USA.
Summary
Glucose triggers insulin release from alginate hydrogels. This novel drug-delivery system uses enzyme-catalyzed reactions within the particles to control release, offering a new model for therapeutic applications.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Hydrogel Engineering
Background:
- Insulin delivery remains a challenge for diabetes management.
- Alginate hydrogels offer biocompatibility and tunable properties for drug encapsulation.
- Controlled release mechanisms are crucial for effective therapeutic outcomes.
Purpose of the Study:
- To investigate the mechanisms of glucose-triggered insulin release from iron(III)-cross-linked alginate hydrogel particles.
- To explore the role of Fenton-type reactions and free radicals in hydrogel degradation and drug release.
- To develop a theoretical model for predicting and optimizing drug release kinetics.
Main Methods:
- Synthesis of platelet-shaped alginate hydrogel particles encapsulating glucose oxidase-conjugated silica nanoparticles.
- Induction of insulin release using glucose and monitoring of particle structural changes.
- Application of a theoretical model to experimental data for analysis of release mechanisms.
Main Results:
- Glucose triggers insulin release by increasing hydrogel porosity through enzymatic reactions and Fenton-type chemistry.
- Iron(III) cations catalyze the conversion of hydrogen peroxide to free radicals, decreasing hydrogel density.
- The hydrogel particles maintain structural integrity while allowing for controlled insulin release.
Conclusions:
- The developed alginate hydrogel system provides a glucose-responsive platform for insulin delivery.
- The study elucidates the underlying chemical mechanisms governing controlled drug release.
- This research offers a promising model for the design of advanced drug-release systems.
Related Concept Videos
Insulin Secretory Vesicles
7.2K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K
Glucagon-like Receptor Agonists
1.1K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.9K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.9K
Hormones Regulating Blood Glucose
7.8K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
7.8K
Hypoglycemia and Glucagon
1.1K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.1K

